PJ

Prateek Jindal

Active Director Director DIN 11139331
DIN 11139331 First appointment Jun 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Prateek Jindal

Data last updated:

Prateek Jindal is a Director at Truelight Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11139331
Primary Designation Director
Industry Pharma
First Appointment 04 Jun 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Jun 20252025Active

Board colleagues of Prateek Jindal

NameDINCompanyDesignation
Divya Agrawal11139330Truelight Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Truelight Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Prateek Jindal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prateek Jindal

Prateek Jindal currently holds 1 directorship: Truelight Pharmaceuticals Private Limited (Director, since 04 Jun 2025).

Prateek Jindal was first appointed on 04 Jun 2025 as Director at Truelight Pharmaceuticals Private Limited.

The current boards of Prateek Jindal's companies include Divya Agrawal (Truelight Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available